Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
2(33.3%)
Phase 2
2(33.3%)
Phase 3
1(16.7%)
N/A
1(16.7%)
6Total
Phase 1(2)
Phase 2(2)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT06652737Phase 1Completed

Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Role: collaborator

NCT04300309Phase 2Terminated

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria

Role: collaborator

NCT06618885Phase 1Active Not Recruiting

Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso

Role: collaborator

NCT06225739Completed

Evaluation of Electronic Pregnancy Registers and Mobile Applications for Monitoring Pregnancy Outcomes ( EVAPREAP )

Role: collaborator

NCT05878366Not ApplicableCompleted

Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)

Role: collaborator

NCT03614533Phase 2Completed

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Role: collaborator

NCT06162078Unknown

Malaria Burden in Pregnant Women and the Incidence of Pregnancy in a Cohort of Nulligravida

Role: lead

NCT05426187Active Not Recruiting

Follow-up of Immunological Pattern and Pregnancy Outcomes in Women Previously Received Placental Malaria Vaccine

Role: lead

NCT04695197Phase 3Completed

Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso

Role: collaborator

NCT04601714Completed

Baseline Cohort Malaria Morbidity Study

Role: lead

NCT04312906Completed

A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in Africa

Role: collaborator

NCT04265573Completed

Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies

Role: lead

All 12 trials loaded